Deciphering the Role of Circular RNAs in ALKpositive Anaplastic Large-cell Lymphoma

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

June 1, 2023

Study Completion Date

December 31, 2025

Conditions

ALK-Positive Anaplastic Large Cell Lymphoma

Interventions

BIOLOGICAL

RNAseq

there is no intervention done.

Trial Locations (1)

IUCT-Oncopole University Hospital, Toulouse

All Listed Sponsors

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

University Hospital, Toulouse

OTHER